Bio-Rad: Switching Costs and Competitive Dynamics in Single-Cell & Digital PCR
Former Director at Bio-Rad Laboratories
inpractise.com/articles/bio-rad-switching-costs-and-competitive-dynamics-in-single-cell-and-digital-pcr
Former Director at Bio-Rad Laboratories
Interview Transcript
This is a snippet of the transcript.Contact Salesto get full access.
If you go to the core lab and say, "Hey, you've got a machine that produces this information, I'd like to offer you a cheaper machine that produces the same information," why is there a switching cost involved?
There are switching costs because, firstly, they need to prove that it's better. For example, Bio-Rad doesn't offer the same level of cell analysis; it does half the number of cells.
This is a snippet of the transcript.Contact Salesto get full access.
Related Content
Vitrolife: Genetic Testing Lab Operations
Former Senior Scientific Executive at Igenomix
Illumina & The Evolution of Next-Generation Sequencing
Former Director at Illumina, Thermo Fisher Scientific and Pillar Biosciences
10x Genomics: Visium, NanoString Tech & Future of Single-Cell Analysis
Former Sales Manager at 10x Genomics
Waters Corporation: Product Innovation, Support Services & Switching Cost
Former Senior Scientist at Waters Corporation
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.